What is Lightship?
Lightship operates as a premier clinical trial services provider, fundamentally redefining how research is conducted by moving away from rigid, site-based models. The company specializes in the design and execution of decentralized and hybrid clinical trials, effectively removing the traditional barriers that often impede patient participation. By integrating advanced digital connectivity with a physical infrastructure that includes Mobile Research Units and a dedicated network of mobile nurses, Lightship brings the trial directly to the patient's community.
This innovative approach not only enhances the quality of data collection but also significantly improves patient retention and diversity in clinical studies. As a leader in the digital health space, Lightship is effectively modernizing the clinical research landscape, ensuring that medical breakthroughs are more accessible to a broader, more representative population.
How much funding has Lightship raised?
Lightship has raised a total of $64.9M across 3 funding rounds:
Series A
$4.9M
Series B
$20M
Unspecified
$40M
Series A (2019): $4.9M, investors not publicly disclosed
Series B (2020): $20M led by Define Ventures Management, McKesson, Brook Byers, Marc Benioff, and Khosla Ventures
Unspecified (2021): $40M supported by Define Ventures Management, TIME Ventures, Khosla Ventures, and McKesson
Key Investors in Lightship
Define Ventures Management
Define Ventures is an early-stage venture capital firm that focuses on investing in digital health companies. The firm was formed in 2019 and is headquartered in San Francisco, California.
McKesson
McKesson Corporation is a publicly traded healthcare company providing pharmaceutical distribution, medical supplies, and healthcare technology solutions to hospitals and health systems globally.
Khosla Ventures
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies, with a significant focus on the health and enterprise sectors.
What's next for Lightship?
With the support of its latest strategic investment, Lightship is poised to expand its operational footprint and further refine its proprietary technology stack. The company is expected to focus on scaling its fleet of Mobile Research Units and enhancing its digital platform to support more complex, multi-site trial protocols. As the demand for decentralized research solutions continues to rise, Lightship's ability to provide a seamless, patient-first experience will be critical in maintaining its competitive advantage.
Looking ahead, the firm is likely to pursue deeper integrations with pharmaceutical partners and healthcare systems, aiming to standardize the hybrid trial model as the industry benchmark. By maintaining its focus on operational excellence and technological innovation, Lightship is set to remain a cornerstone of the next generation of clinical research infrastructure.
